CommercialCoverageMedium impact
Voice Prosthesis for Voice Rehabilitation Following Total Laryngectomy (CPB 0560, reviewed 2025-12-02)
Aetna·ENT (Ear, Nose & Throat), Speech Therapy, Oncology·Medical Policy
Effective date
Dec 2, 2025
We identified it
Aug 14, 2026
Summary
Aetna has issued a fresh clinical policy (CPB 0560) clarifying medical necessity coverage for voice prosthesis devices following total laryngectomy. The policy covers indwelling tracheo-esophageal (TE) prostheses, non-indwelling prostheses (Provox NiD), hand-held artificial larynx devices, and replacement prostheses every 3-6 months when recommended by a laryngologist or speech-language pathologist. Pneumatic Bionic Voice Prostheses and TE voice prosthesis insufflators remain experimental/investigational and are not covered.
Action Required
By December 2, 2025: Billing team must implement this policy in the billing system and update prior authorization protocols. REQUIREMENTS: (1) CPT 31611 and HCPCS L8507, L8509, L8511, L8512, L8513, L8514, L8515 require verification that the procedure is recommended by a laryngologist or speech-language pathologist before processing; (2) CPT 31611 and laryngectomy codes (31360-31365) require ICD-10 documentation of covered diagnoses (C32.0-C32.9, D02.0, D14.1, or Z85.21); (3) DENY claims for Pneumatic Bionic Voice Prostheses and TE voice prosthesis insufflators as experimental/investigational; (4) Update encounter forms and templates to capture provider specialty (laryngologist or SLP) for voice prosthesis cases; (5) Establish replacement authorization protocol allowing medically necessary replacements every 3-6 months for indwelling TE prostheses. Failure to require provider recommendation documentation will result in claim denials. AFFECTED STAFF: Billing team (system updates), Prior Auth team (template updates), Front desk (collection of provider specialty at check-in).